Ocumension Therapeutics 歐康維視生物

Pay for financial year ended 2022-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Cao, Yanling 曹彥凌 NED
2 Chen, Lian Yong 陳連勇 NED, Ch
3 He, Lianming 何連明 INED 40 40
4 Hu, Zhaopeng 胡兆鵬 ED 1,920 192 42 2,618 4,772
5 Huang, Yiran (1954) 黃翼然 INED 162 162
6 Li, Wei (Cstone) 李偉 NED
7 Liu, Ye (1971) 劉曄 CEO 2,647 2,459 144,095 149,201
8 Wang, Yumeng (1990) 王雨濛 NED
9 Wu, Anthony Ting Yuk 胡定旭 INED 647 647
10 Zhang, Zhenyu (1974) 張振宇 INED 121 121
Total 970 4,567 2,651 42 146,713 154,943

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,095 6,562 3,017 53 30,478 41,205 Report
2023-12-31 1,035 6,198 1,908 46 69,728 78,915 Report
2022-12-31 970 4,567 2,651 42 146,713 154,943 Report
2021-12-31 747 5,337 1,583 53 124,393 132,113 Report
2020-12-31 534 4,139 2,556 0 163,947 171,176 Report
Total 4,381 26,803 11,715 194 535,259 578,352

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top